pLenti PGK GFP Puro (w509-5) Citations (21)
Originally described in: A versatile viral system for expression and depletion of proteins in mammalian cells.Campeau E, Ruhl VE, Rodier F, Smith CL, Rahmberg BL, Fuss JO, Campisi J, Yaswen P, Cooper PK, Kaufman PD. PLoS One. 2009 Aug 6;4(8):e6529. PubMed Journal
Articles Citing pLenti PGK GFP Puro (w509-5)
| Articles |
|---|
| PAD2 overexpression in transgenic mice promotes spontaneous skin neoplasia. McElwee JL, Mohanan S, Horibata S, Sams KL, Anguish LJ, McLean D, Cvitas I, Wakshlag JJ, Coonrod SA. Cancer Res. 2014 Nov 1;74(21):6306-17. doi: 10.1158/0008-5472.CAN-14-0749. Epub 2014 Sep 11. PubMed |
| Induced Pluripotent Stem Cells With Six Reprogramming Factors From Prairie Vole, Which Is an Animal Model for Social Behaviors. Katayama M, Hirayama T, Horie K, Kiyono T, Donai K, Takeda S, Nishimori K, Fukuda T. Cell Transplant. 2016;25(5):783-96. doi: 10.3727/096368916X690502. Epub 2016 Jan 15. PubMed |
| Analysis of Nuclear Lamina Proteins in Myoblast Differentiation by Functional Complementation. Tapia O, Gerace L. Methods Mol Biol. 2016;1411:177-94. doi: 10.1007/978-1-4939-3530-7_11. PubMed |
Redundancy of human ATG4 protease isoforms in autophagy and LC3/GABARAP processing revealed in cells.
Agrotis A, Pengo N, Burden JJ, Ketteler R.
Autophagy. 2019 Jan 21. doi: 10.1080/15548627.2019.1569925.
PubMed
Associated Plasmids |
| Human lung organoids develop into adult airway-like structures directed by physico-chemical biomaterial properties. Dye BR, Youngblood RL, Oakes RS, Kasputis T, Clough DW, Spence JR, Shea LD. Biomaterials. 2020 Mar;234:119757. doi: 10.1016/j.biomaterials.2020.119757. Epub 2020 Jan 6. PubMed |
| Protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) drives migration and progression of T-cell acute lymphoblastic leukemia in vitro and in vivo. Wei M, Haney MG, Rivas DR, Blackburn JS. Oncogenesis. 2020 Jan 30;9(1):6. doi: 10.1038/s41389-020-0192-5. PubMed |
| In Vitro and In Vivo Development of the Human Airway at Single-Cell Resolution. Miller AJ, Yu Q, Czerwinski M, Tsai YH, Conway RF, Wu A, Holloway EM, Walker T, Glass IA, Treutlein B, Camp JG, Spence JR. Dev Cell. 2020 Apr 6;53(1):117-128.e6. doi: 10.1016/j.devcel.2020.01.033. Epub 2020 Feb 27. PubMed |
| MPV17 does not control cancer cell proliferation. Canonne M, Wanet A, Nguyen TTA, Khelfi A, Ayama-Canden S, Van Steenbrugge M, Fattaccioli A, Sokal E, Najimi M, Arnould T, Renard P. PLoS One. 2020 Mar 10;15(3):e0229834. doi: 10.1371/journal.pone.0229834. eCollection 2020. PubMed |
| Targeted delivery of siRNAs against hepatocellular carcinoma-related genes by a galactosylated polyaspartamide copolymer. Perrone F, Craparo EF, Cemazar M, Kamensek U, Drago SE, Dapas B, Scaggiante B, Zanconati F, Bonazza D, Grassi M, Truong N, Pozzato G, Farra R, Cavallaro G, Grassi G. J Control Release. 2021 Feb 10;330:1132-1151. doi: 10.1016/j.jconrel.2020.11.020. Epub 2020 Nov 17. PubMed |
| How Cancer Cells Invade Bladder Epithelium and Form Tumors: The Mouse Bladder Tumor Model as a Model of Tumor Recurrence in Patients. Erman A, Kamensek U, Dragin Jerman U, Pavlin M, Cemazar M, Veranic P, Romih R. Int J Mol Sci. 2021 Jun 13;22(12). pii: ijms22126328. doi: 10.3390/ijms22126328. PubMed |
| GLI3 Is Stabilized by SPOP Mutations and Promotes Castration Resistance via Functional Cooperation with Androgen Receptor in Prostate Cancer. Burleson M, Deng JJ, Qin T, Duong TM, Yan Y, Gu X, Das D, Easley A, Liss MA, Yew PR, Bedolla R, Kumar AP, Huang TH, Zou Y, Chen Y, Chen CL, Huang H, Sun LZ, Boyer TG. Mol Cancer Res. 2022 Jan;20(1):62-76. doi: 10.1158/1541-7786.MCR-21-0108. Epub 2021 Oct 5. PubMed |
| Disrupting the HDAC6-ubiquitin interaction impairs infection by influenza and Zika virus and cellular stress pathways. Wang L, Moreira EA, Kempf G, Miyake Y, Oliveira Esteves BI, Fahmi A, Schaefer JV, Dreier B, Yamauchi Y, Alves MP, Pluckthun A, Matthias P. Cell Rep. 2022 Apr 26;39(4):110736. doi: 10.1016/j.celrep.2022.110736. PubMed |
| The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer. Giacomini A, Turati M, Grillo E, Rezzola S, Ghedini GC, Schuind AC, Foglio E, Maccarinelli F, Faletti J, Filiberti S, Chambery A, Valletta M, Melocchi L, Gofflot S, Chiavarina B, Turtoi A, Presta M, Ronca R. Exp Hematol Oncol. 2023 Sep 25;12(1):82. doi: 10.1186/s40164-023-00441-y. PubMed |
| Human amniotic membrane inhibits migration and invasion of muscle-invasive bladder cancer urothelial cells by downregulating the FAK/PI3K/Akt/mTOR signalling pathway. Janev A, Ramuta TZ, Jerman UD, Obradovic H, Kamensek U, Cemazar M, Kreft ME. Sci Rep. 2023 Nov 6;13(1):19227. doi: 10.1038/s41598-023-46091-2. PubMed |
| Condensation of RNase L promotes its rapid activation in response to viral infection in mammalian cells. Cusic R, Burke JM. Sci Signal. 2024 May 21;17(837):eadi9844. doi: 10.1126/scisignal.adi9844. Epub 2024 May 21. PubMed |
| Co-option of mitochondrial nucleic acid sensing pathways by HSV-1 UL12.5 for reactivation from latent Infection. Cuddy SR, Flores ME, Krakowiak PA, Whitford AL, Dochnal SA, Babnis A, Miyake T, Tigano M, Engel DA, Cliffe AR. bioRxiv [Preprint]. 2024 Jul 9:2024.07.06.601241. doi: 10.1101/2024.07.06.601241. PubMed |
| Co-option of mitochondrial nucleic acid-sensing pathways by HSV-1 UL12.5 for reactivation from latent infection. Krakowiak PA, Flores ME, Cuddy SR, Whitford AL, Dochnal SA, Babnis A, Miyake T, Tigano M, Engel DA, Cliffe AR. Proc Natl Acad Sci U S A. 2025 Jan 28;122(4):e2413965122. doi: 10.1073/pnas.2413965122. Epub 2025 Jan 24. PubMed |
| Phases of tight junction barrier disruption during transurothelial migration of invasive urothelial cancer cells. Kuret T, Kreft ME, Veranic P, Cemazar M, Pavlin M, Jerman UD. Sci Rep. 2025 Apr 15;15(1):12975. doi: 10.1038/s41598-025-96267-1. PubMed |
| De novo assembly of RNA m(6)A modification factors into viral genome-associated nuclear bodies drives HCMV RNA accumulation. Grande RC, Lin CC, Cammer M, Emesom ED, Khurram MA, Boutell C, Denes LT, Lionnet T, Wilson AC, Mohr I. Cell Rep. 2025 Jul 22;44(7):115826. doi: 10.1016/j.celrep.2025.115826. Epub 2025 Jun 24. PubMed |
| JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms. Maslah N, Kaci N, Roux B, Alexe G, Marie R, Pasquer H, Verger E, De Oliveira RD, Culeux C, Mlayah B, Gauthier N, Gonzales F, Zhao LP, Ganesan S, Gou P, Ling F, Soret-Dulphy J, Parquet N, Vainchenker W, Raffoux E, Padua RA, Giraudier S, Marty C, Plo I, Lobry C, Stegmaier K, Puissant A, Kiladjian JJ, Cassinat B, Benajiba L. Nat Commun. 2025 Jul 8;16(1):6270. doi: 10.1038/s41467-025-60884-1. PubMed |
| Imaging progenitor cell differentiation during central nervous system remyelination using an MRI gene reporter. Brechbuhl EES, Hill MFE, Chen CZ, Gaitsch HF, Ros S, Porcu L, Wright AJ, Reich DS, Franklin RJM, Brindle KM. bioRxiv [Preprint]. 2025 Sep 15:2025.09.10.674209. doi: 10.1101/2025.09.10.674209. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.